Thanks to improved therapies, more than 80 percent of U.S. children with cancer now become long-term survivors. An estimated 420,000 childhood cancer survivors live in the U.S. alone, with many more around the world.
St. Jude leads some of the world’s most ambitious research programs in childhood cancer survivorship. With unique data gathered from tens of thousands of cancer survivors, we are identifying the long-term effects of cancer therapy; finding better ways to predict health risks; and working to help survivors everywhere live longer, healthier lives.
St. Jude LIFE is an unprecedented study in which thousands of former St. Jude cancer patients periodically return to our campus for comprehensive clinical evaluations throughout their adult lives.
Findings from this unique cohort have yielded novel insights into the long-term effects of pediatric cancers and their treatments, and are informing new approaches to improve long-term survivor health.
St. Jude is the coordinating center for the Childhood Cancer Survivor Study (CCSS). This multi-institutional collaboration is the world’s single largest resource for survivorship research.
Through this initiative, we are analyzing comprehensive treatment exposure and self-reported outcomes data for more than 35,000 survivors, including thousands who were treated at St. Jude.
St. Jude faculty and staff include some of the world’s leading investigators and clinicians in pediatric cancer survivorship.
As well as our unique research programs, we provide world-class clinical care for survivors who have completed their active therapy at St. Jude. Patients whose disease has been in remission for five years receive specialized care at our After Completion of Therapy (ACT) clinic. Survivors graduating from St. Jude clinical programs may receive cancer-related consultation services through the St. Jude Alumnus Office.